Why the study?
Vaccination against foot-and-mouth disease is limited by antigenic diversity, immunogen instability, and short duration of protection, prompting further dissection of the protective mechanisms of neutralizing antibodies M8 and M170.
Answers are grounded in this paper and cite their sources.
Neutralizing antibodies M8 and M170 provide prophylactic and therapeutic protection against foot-and-mouth disease virus in guinea pigs by disrupting virus-receptor interactions.
Outbreaks of Foot-and-mouth disease (FMD) caused by FMD virus result in significant economic losses. Vaccination is helpful, but the benefits are diminished with antigenic diversity within serotypes, instability of the immunogen and inability to confer protection for long durations. Here we have further dissected the mechanisms underpinning the protective efficacy of two previously reported neutralizing antibodies (NAbs), M8 and M170. The atomic details of the epitopes of M8 and M170 unveiled suggest that protection is conferred by disrupting the virus-receptor interactions. Consequently, administration of these NAbs conferred prophylactic and therapeutic benefit in guinea pigs, raising the possibility of administering NAbs before or during vaccination to confer immediate protection; well before the bolstering of the immune response by the vaccine. Differences in the residues and the conformation of elements making up the epitopes explain the differences in specificities of M8 and M170. An ability to bind 146S viral particles specifically, but not 12S degraded components, highlights a likely role for M170 in the quality control of vaccines.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: